CLINICAL ROLE -
Current Standards of Care in Platinum-Resistant Ovarian Cancer
Folate receptor α may be an important treatment target for ovarian tumors.
The Impact of COVID-19 on Cervical, Breast Cancer Screenings
Breast cancer screening guidelines using mammography vary among guiding bodies, including the American Cancer Society and the American Academy of Family Physicians.
Developing Standardized Concentrations, Overcoming Barriers
Simplifying processes reduces errors in compounding, IV pump programming, and physician order entry.
Assessing the Impact of Patient Assistance Programs on Financial Toxicity in Oral Oncology
PAPs can significantly reduce OOP costs for patients.
Multiple Options Mean More Time for Patients With Indolent Lymphoma
The treatment landscape for relapsed/refractory MZL and follicular lymphoma (FL) is shifting from intravenous chemotherapy and monoclonal antibodies to oral oncolytic therapy or CD19-directed chimeric antigen receptor (CAR) T-cell therapy.
Brown Bag Consult®: Chronic Lymphocytic Leukemia
A patient with CLL relies on his pharmacy team for support.
Oncology Pharmacists Are Essential in Therapeutic Interchange
Biosimilar therapeutic interchange processes can mitigate high costs of cancer drugs.
The Role of Pharmacists in Improving Patient Access to Oncology Drugs
The efforts of pharmacists remain critical to the success of treatment outcomes.
Navigating Patient Treatment in Oncology to Fill Gaps in Care
Oncology pharmacists can help ensure patient access to lifesaving therapies.
2 Clarke Drive Cranbury, NJ 08512